Table 3.

ERG rearrangements are associated with magnitude of PSA decline on abiraterone acetate

ERG rearrangedERG normalTotal
I
    No204262
    ≥90% decline12315
    Total324577
P = 0.001
II
    No122739
    ≥50% decline201838
    Total324577
P = 0.07
III
    No122762
    50–89%81538
    ≥90% decline12315
    Total324577
P = 0.007
  • NOTE: The number of patients with a PSA decline of ≥90% (I), ≥50% (II), and ≥50–89% and ≥90% (III) are divided by ERG gene status.